Marit M. van Buuren

Tumor Exome Analysis Reveals Neoantigen-Specific T-Cell Reactivity in an Ipilimumab-Responsive Melanoma

Nienke van Rooij, Marit M. van Buuren, Daisy Philips et al. · Journal of Clinical Oncology · 2013 · 798 citations · Full text

Immunology, Immune Regulation, Immunoediting +23

High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4+ T cells in human melanoma

Carsten Linnemann, Marit M. van Buuren, Laura Bies et al. · Nature Medicine · 2014 · 679 citations

Cancer Immunosurveillance, Human Melanoma, T-regulatory Cell +10

Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction

Daniel K. Wells, Marit M. van Buuren, Kristen K. Dang et al. · Cell · 2020 · 507 citations · Full text

Tumor Immunology, Cancer Immunosurveillance, Medicine +12

Neoantigen landscape dynamics during human melanoma–T cell interactions

Els M.E. Verdegaal, Noel F.C.C. de Miranda, Marten Visser et al. · Nature · 2016 · 453 citations

Melanoma, Tumor Immunity, Neoantigen Landscape Dynamics +3

Targeting of cancer neoantigens with donor-derived T cell receptor repertoires

Erlend Strønen, Mireille Toebes, Sander Kelderman et al. · Science · 2016 · 443 citations · Full text